<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25997678</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0290</ISSN><JournalIssue CitedMedium="Internet"><Volume>112</Volume><Issue>10</Issue><PubDate><Year>2015</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Biotechnology and bioengineering</Title><ISOAbbreviation>Biotechnol Bioeng</ISOAbbreviation></Journal><ArticleTitle>Enhanced enterovirus 71 virus-like particle yield from a new baculovirus design.</ArticleTitle><Pagination><StartPage>2005</StartPage><EndPage>2015</EndPage><MedlinePgn>2005-15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/bit.25625</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is responsible for the outbreaks of hand-foot-and-mouth disease in the Asia-Pacific region. To produce the virus-like particle (VLP) vaccine, we previously constructed recombinant baculoviruses to co-express EV71 P1 polypeptide and 3CD protease using the Bac-to-Bac(&#xae;) vector system. The recombinant baculoviruses resulted in P1 cleavage by 3CD and subsequent VLP assembly in infected insect cells, but caused either low VLP yield or excessive VLP degradation. To tackle the problems, here we explored various expression cassette designs and flashBAC GOLD&#x2122; vector system which was deficient in v-cath and chiA genes. We found that the recombinant baculovirus constructed using the flashBAC GOLD&#x2122; system was insufficient to improve the EV71 VLP yield. Nonetheless, BacF-P1-C3CD, a recombinant baculovirus constructed using the flashBAC GOLD(TM) system to express P1 under the polh promoter and 3CD under the CMV promoter, dramatically improved the VLP yield while alleviating the VLP degradation. Infection of High Five(TM) cells with BacF-P1-C3CD enhanced the total and extracellular VLP yield to &#x2248;268 and &#x2248;171&#x2009;mg/L, respectively, which enabled the release of abundant VLP into the supernatant and simplified the downstream purification. Intramuscular immunization of mice with 5&#x2009;&#x3bc;g purified VLP induced cross-protective humoral responses and conferred protection against lethal virus challenge. Given the significantly improved extracellular VLP yield (&#x2248;171&#x2009;mg/L) and the potent immunogenicity conferred by 5&#x2009;&#x3bc;g VLP, one liter High Five(TM) culture produced &#x2248;12,000 doses of purified vaccine, thus rendering the EV71 VLP vaccine economically viable and able to compete with inactivated virus vaccines.</AbstractText><CopyrightInformation>&#xa9; 2015 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shih-Yeh</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Chia-Tsui</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Life Science, National Taiwan Normal University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wan-Hua</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Cheng-Ping</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Wen-Chin</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jyh-Yuan</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Center for Research, Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Hsueh-Ling</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yu-Chen</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan. ychu@mx.nthu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biotechnol Bioeng</MedlineTA><NlmUniqueID>7502021</NlmUniqueID><ISSNLinking>0006-3592</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058425">Vaccines, Virus-Like Particle</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022701">Virosomes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001208" MajorTopicYN="N">Asia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016367" MajorTopicYN="Y">Baculoviridae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007273" MajorTopicYN="N">Injections, Intramuscular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007313" MajorTopicYN="N">Insecta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058425" MajorTopicYN="N">Vaccines, Virus-Like Particle</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022701" MajorTopicYN="N">Virosomes</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">VLP</Keyword><Keyword MajorTopicYN="N">baculovirus</Keyword><Keyword MajorTopicYN="N">hand-foot-and-mouth disease</Keyword><Keyword MajorTopicYN="N">protease</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25997678</ArticleId><ArticleId IdType="pmc">PMC7161748</ArticleId><ArticleId IdType="doi">10.1002/bit.25625</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baek JO, Seo JW, Kim IH, Kim CH. 2011. Production and purification of human papillomavirus type 33 L1 virus&#x2010;like particles from Spodoptera frugiperda 9 cells using two&#x2010;step column chromatography. Protein Expr Purif 75:211&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">20716445</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger I, Fitzgerald DJ, Richmond TJ. 2004. Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol 22:1583&#x2013;1587.</Citation><ArticleIdList><ArticleId IdType="pubmed">15568020</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng A, Fung CP, Liu CC, Lin YT, Tsai HY, Chang SC, Chou AH, Chang JY, Jiang RH, Hsieh YC, Su IJ, Chong PC, Hsieh SM. 2013. A phase I, randomized, open&#x2010;label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine. Vaccine 31:2471&#x2013;2476.</Citation><ArticleIdList><ArticleId IdType="pubmed">23541623</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung CY, Chen CY, Lin SY, Chung YC, Chiu HY, Chi WK, Lin YL, Chiang BL, Chen WJ, Hu YC. 2010. Enterovirus 71 virus&#x2010;like particle vaccine: Improved production conditions for enhanced yield. Vaccine 28:6951&#x2013;6957.</Citation><ArticleIdList><ArticleId IdType="pubmed">20797455</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, Chou ST, Hu YC. 2008. Immunization with virus&#x2010;like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26:1855&#x2013;1862.</Citation><ArticleIdList><ArticleId IdType="pubmed">18329759</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung YC, Huang JH, Lai CW, Sheng HC, Shih SR, Ho MS, Hu YC. 2006. Expression, purification and characterization of enterovirus 71 virus&#x2010;like particles. World J Gastroenterol 12:921&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066158</ArticleId><ArticleId IdType="pubmed">16521221</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz PE, Martins PC, Alves PM, Peixoto CC, Santos H, Moreira JL, Carrondo MJT. 1999. Proteolytic activity in infected and noninfected insect cells: Degradation of HIV&#x2010;1 Pr55gag particles. Biotechnol Bioeng 65:133&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">10458733</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes F, Teixeira AP, Carinhas N, Carrondo MJ, Alves PM. 2013. Insect cells as a production platform of complex virus&#x2010;like particles. Expert Rev Vaccines 12:225&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">23414412</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotoh T, Miyazaki Y, Sato W, Kikuchi K&#x2010;I, Bentley WE. 2001. Proteolytic activity and recombinant protein production in virus&#x2010;infected Sf&#x2010;9 insect cell cultures supplemented with carboxyl and cysteine protease inhibitors. J Biosci Bioeng 92:248&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">16233092</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawtin RE, Zarkowska T, Arnold K, Thomas CJ, Gooday GW, King LA, Kuzio JA, Possee RD. 1997. Liquefaction of Autographa californica Nucleopolyhedrovirus&#x2010;infected insects is dependent on the integrity of virus&#x2010;encoded chitinase and cathepsin genes. Virology 238:243&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">9400597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitchman RB, Locanto E, Possee RD, King LA. 2011. Optimizing the baculovirus expression vector system. Methods 55:52&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">21945427</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitchman RB, Possee RD, Crombie AT, Chambers A, Ho K, Siaterli E, Lissina O, Sternard H, Novy R, Loomis K, Bird LE, Owens RJ, King LA. 2010a. Genetic modification of a baculovirus vector for increased expression in insect cells. Cell Biol Toxicol 26:57&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">19655260</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitchman RB, Possee RD, Siaterli E, Richards KS, Clayton AJ, Bird LE, Owens RJ, Carpentier DCJ, King FL, Danquah JO, Spink KG, King LA. 2010b. Improved expression of secreted and membrane&#x2010;targeted proteins in insect cells. Biotechnol Appl Biochem 56:85&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">20441568</ArticleId></ArticleIdList></Reference><Reference><Citation>Hom LG, Volkman LE. 2000. Autographa californica M nucleopolyhedrovirus chiA is required for processing of V&#x2010;CATH. Virology 277:178&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">11062048</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YC, Bentley WE. 1999. Enhancing yield of infectious bursal disease virus structural proteins in baculovirus expression systems: Focus on media, protease inhibitors, and dissolved oxygen. Biotechnol Prog 15:1065&#x2013;1071.</Citation><ArticleIdList><ArticleId IdType="pubmed">10585191</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YC, Hsu TA, Huang JH, Ho MS, Ho YC. 2003. Formation of enterovirus&#x2010;like particle aggregates by recombinant baculoviruses co&#x2010;expressing P1 and 3CD in insect cells. Biotechnol Lett 25:919&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pubmed">12889824</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YC, Yao K, Wu TY. 2008. Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Rev Vaccines 7:363&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">18393606</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaba SA, Salcedo AM, Wafula PO, Vlak JM, van Oers MM. 2004. Development of a chitinase and v&#x2010;cathepsin negative bacmid for improved integrity of secreted recombinant proteins. J Virol Methods 122:113&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">15488628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener TK, Premanand B, Kwang J. 2013. Immune responses to baculovirus&#x2010;displayed enterovirus 71 VP1 antigen. Expert Rev Vaccines 12:357&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">23560917</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer F, Nakowitsch S, Messner P, Palmberger D, Ferko B, Grabherr R. 2010a. Swine&#x2010;origin pandemic H1N1 influenza virus&#x2010;like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice. Biotechnol J 5:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4388400</ArticleId><ArticleId IdType="pubmed">20041443</ArticleId></ArticleIdList></Reference><Reference><Citation>Krammer F, Schinko T, Palmberger D, Tauer C, Messner P, Grabherr R. 2010b. Trichoplusia ni cells (High Five(TM)) are highly efficient for the production of influenza A virus&#x2010;like particles: A comparison of two insect cell lines as production platforms for influenza vaccines. Mol Biotechnol 45:226&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4388404</ArticleId><ArticleId IdType="pubmed">20300881</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung YA, Hung CT, Liu YC, Shih SR. 2014. Update on the development of enterovirus 71 vaccines. Expert Opin Biol Ther 14:1455&#x2013;1464.</Citation><ArticleIdList><ArticleId IdType="pubmed">24989170</ArticleId></ArticleIdList></Reference><Reference><Citation>Li HY, Han JF, Qin CF, Chen R. 2013. Virus&#x2010;like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. Vaccine 31:3281&#x2013;3287.</Citation><ArticleIdList><ArticleId IdType="pubmed">23726823</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YP, Liang ZL, Xia JL, Wu JY, Wang L, Song LF, Mao QY, Wen SQ, Huang RG, Hu YS, Yao X, Miao X, Wu X, Li RC, Wang JZ, Yin WD. 2014. Immunogenicity, safety, and immune persistence of a novel inactivated human enterovirus 71 vaccine: A phase II, randomized, double&#x2010;blind, placebo&#x2010;controlled trial. J Infect Dis 209:46&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">23922377</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, Wang J. 2014. EV71 vaccine, an invaluable gift for children. Clin Transl Immunology 3:e28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4237031</ArticleId><ArticleId IdType="pubmed">25505956</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SY, Chiu HY, Chiang BL, Hu YC. 2015. Development of EV71 virus&#x2010;like particle production and purification processes. Vaccine. Epub ahead of print doi: 10.1016/j.vaccine.2015.04.077</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.077</ArticleId><ArticleId IdType="pubmed">25939279</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SY, Chung YC, Chiu HY, Chi WK, Chiang BL, Hu YC. 2014a. Evaluation of the stability of enterovirus 71 virus&#x2010;like particle. J Biosci Bioeng 117:366&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pubmed">24140131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SY, Chung YC, Hu YC. 2014b. Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Rev Vaccines 13:1501&#x2013;1521.</Citation><ArticleIdList><ArticleId IdType="pubmed">25155825</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Hu YC, Liang CC, Lin SY, Liang YC, Yuan HP, Chiang BL. 2014c. Enterovirus&#x2010;71 virus&#x2010;like particles induce the activation and maturation of human monocyte&#x2010;derived dendritic cells through TLR4 signaling. PLoS ONE 9:e111496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4216083</ArticleId><ArticleId IdType="pubmed">25360749</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Yu CI, Hu YC, Tsai TJ, Kuo YC, Chi WK, Lin AN, Chiang BL. 2012. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus&#x2010;like particles. Vaccine 30:1305&#x2013;1312.</Citation><ArticleIdList><ArticleId IdType="pubmed">22214888</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Guo MS, Lin FHY, Hsiao KN, Chang KHW, Chou AH, Wang YC, Chen YC, Yang CS, Chong PCS. 2011. Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum&#x2010;free microcarrier bioreactor system. PLoS ONE 6:e20005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094384</ArticleId><ArticleId IdType="pubmed">21603631</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Wang W, Duo J, Hao Y, Ma C, Li W, Lin S, Gao X, Liu X, Xu Y. 2010. Combined peptides of human enterovirus 71 protect against virus infection in mice. Vaccine 28:7444&#x2013;7451.</Citation><ArticleIdList><ArticleId IdType="pubmed">20831911</ArticleId></ArticleIdList></Reference><Reference><Citation>Lua LHL, Connors NK, Sainsbury F, Chuan YP, Wibowo N, Middelberg APJ. 2014. Bioengineering virus&#x2010;like particles as vaccines. Biotechnol Bioeng 111:425&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">24347238</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu K, Wang GC, He YL, Han JF, Ye Q, Qin CF, Chen R. 2015. Crystal structures of EV71 recombinant virus particles provide insights into vaccine design. J Biol Chem Epub ahead of print doi: 10.1074/jbc.M1114.624536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M1114.624536</ArticleId><ArticleId IdType="pmc">PMC4318995</ArticleId><ArticleId IdType="pubmed">25492868</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahonen AJ, Airenne KJ, Purola S, Peltomaa E, Kaikkonen MU, Riekkinen MS, Heikura T, Kinnunen K, Roschier MM, Wirth T, Yla&#x2010;Herttuala S. 2007. Post&#x2010;transcriptional regulatory element boosts baculovirus&#x2010;mediated gene expression in vertebrate cells. J Biotechnol 131:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17617485</ArticleId></ArticleIdList></Reference><Reference><Citation>Maranga L, Rueda P, Antonis AF, Vela C, Langeveld JP, Casal JI, Carrondo MJ. 2002. Large scale production and downstream processing of a recombinant porcine parvovirus vaccine. Appl Microbiol Biotechnol 59:45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">12073130</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortola E, Roy P. 2004. Efficient assembly and release of SARS coronavirus&#x2010;like particles by a heterologous expression system. FEBS Lett 576:174&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7126153</ArticleId><ArticleId IdType="pubmed">15474033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohkawa T, Majima K, Maeda S. 1994. A cysteine protease encoded by the baculovirus Bombyx mori nuclear polyhedrosis virus. J Virol 68:6619&#x2013;6625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC237082</ArticleId><ArticleId IdType="pubmed">8083997</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. 2012. Crystal structure of human enterovirus 71. Science 336:1274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Possee RD, Thomas CJ, King LA. 1999. The use of baculovirus vectors for the production of membrane proteins in insect cells. Biochem Soc Trans 27:928&#x2013;932.</Citation><ArticleIdList><ArticleId IdType="pubmed">10830130</ArticleId></ArticleIdList></Reference><Reference><Citation>Senger T, Schadlich L, Gissmann L, Muller M. 2009. Enhanced papillomavirus&#x2010;like particle production in insect cells. Virology 388:344&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">19409593</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung LY, Chen CL, Lin SY, Li KC, Yeh CL, Chen GY, Lin CY, Hu YC. 2014. Efficient gene delivery into cell lines and stem cells using baculovirus. Nat Protocols 9:1882&#x2013;1899.</Citation><ArticleIdList><ArticleId IdType="pubmed">25010908</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanathan P, Venkaiah B, Kumar MS, Rasheedi S, Vrati S, Bashyam MD, Hasnain SE. 2003. The homologous region sequence (hr1) of Autographa californica multinucleocapsid polyhedrosis virus can enhance transcription from non&#x2010;baculoviral promoters in mammalian cells. J Biol Chem 278:52564&#x2013;52571.</Citation><ArticleIdList><ArticleId IdType="pubmed">14570875</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlak JM, Klinkenberg FA, Zaal KJ, Usmany M, Klinge&#x2010;Roode EC, Geervliet JB, Roosien J, van Lent JW. 1988. Functional studies on the p10 gene of Autographa californica nuclear polyhedrosis virus using a recombinant expressing a p10&#x2010;beta&#x2010;galactosidase fusion gene. J Gen Virol 69:765&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">3128641</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner JM, Pajerowski JD, Daniels CL, McHugh PM, Flynn JA, Balliet JW, Casimiro DR, Subramanian S. 2014. Enhanced production of chikungunya virus&#x2010;like particles using a high&#x2010;pH adapted Spodoptera frugiperda insect cell line. PLoS ONE 9:e94401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3979839</ArticleId><ArticleId IdType="pubmed">24713807</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Li L, Ding S, Huang X, Zhang J, Yin J, Zhong J. 2009. Chicken HS4 insulator significantly improves baculovirus&#x2010;mediated foreign gene expression in insect cells by modifying the structure of neighbouring chromatin in virus minichromosome. J Biotechnol 142:193&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">19539676</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Peng W, Ren J, Hu Z, Xu J, Lou Z, Li X, Yin W, Shen X, Porta C, Walter TS, Evans G, Axford D, Owen R, Rowlands DJ, Wang J, Stuart DI, Fry EE, Rao Z. 2012. A sensor&#x2010;adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol 19:424&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2004. A mouse&#x2010;adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 78:7916&#x2013;7924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye L, Lin JG, Sun YL, Bennouna S, Lo M, Wu QY, Bu ZG, Pulendran B, Compans RW, Yang CL. 2006. Ebola virus&#x2010;like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies. Virology 351:260&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">16678231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Seth A, Wibowo N, Zhao CX, Mitter N, Yu C, Middelberg APJ. 2014. Nanoparticle vaccines. Vaccine 32:327&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pubmed">24295808</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Bai Y, Liu W, Xiao X, Huang Y, Cen S, Chan P, Sun X, Sheng W, Zeng Y. 2013. Immunization of N terminus of enterovirus 71 VP4 elicits cross&#x2010;protective antibody responses. BMC Microbiol 13:287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4029445</ArticleId><ArticleId IdType="pubmed">24320792</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FC, Liang ZL, Li XL, Ge HM, Meng FY, Mao QY, Zhang YT, Hu YM, Zhang ZY, Li JX, Gao F, Chen QH, Zhu QY, Chu K, Wu X, Yao X, Guo HJ, Chen XQ, Liu P, Dong YY, Li FX, Shen XL, Wang JZ. 2013a. Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: A randomised, double&#x2010;blind, placebo&#x2010;controlled phase 2 clinical trial. The Lancet 381:1037&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pubmed">23352749</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, Zhang YT, Yao X, Chu K, Chen QH, Hu YM, Wu X, Liu P, Zhu LY, Gao F, Jin H, Chen YJ, Dong YY, Liang YC, Shi NM, Ge HM, Liu L, Chen SG, Ai X, Zhang ZY, Ji YG, Luo FJ, Chen XQ, Zhang Y, Zhu LW, Liang ZL, Shen XL. 2013b. Efficacy, safety, and immunology of an inactivated alum&#x2010;adjuvant enterovirus 71 vaccine in children in China: A multicentre, randomised, double&#x2010;blind, placebo&#x2010;controlled, phase 3 trial. Lancet 381:2024&#x2013;2032.</Citation><ArticleIdList><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>